PAVmed (PAVM) Income from Non-Controlling Interests (2018 - 2026)
PAVmed (PAVM) posted quarterly Income from Non-Controlling Interests of -$1.5 million for Q4 2025, down 416.96% year-over-year from $471360.3 in Q4 2024, and down 137.9% quarter-over-quarter from -$628000.0 in Q3 2025.
PAVmed (PAVM) Income from Non-Controlling Interests (2018 - 2026) Analysis & Trends
PAVmed's Income from Non-Controlling Interests history runs 8 years deep, the most recent figure standing at -$1.5 million for Q4 2025.
- In Q4 2025, Income from Non-Controlling Interests fell 416.96% year-over-year to -$1.5 million; the TTM figure through Dec 2025 stood at -$2.9 million (up 74.02% YoY), while the FY2025 annual figure was -$2.9 million, up 74.74% from the prior year.
- Income from Non-Controlling Interests for Q4 2025 stood at -$1.5 million, down from -$628000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was -$289000.0 in Q4 2024, with the low at -$4.3 million in Q1 2023.
- The 5-year median for Income from Non-Controlling Interests is -$2.8 million (2022), against an average of -$2.4 million.
- The sharpest annual moves came in 2024 and 2025: Income from Non-Controlling Interests soared 91.43% in 2024, then sank 416.96% in 2025.
- PAVmed's Income from Non-Controlling Interests stood at -$2.5 million in 2021, then slumped by 67.09% to -$4.1 million in 2022, then increased by 18.0% to -$3.4 million in 2023, then jumped by 91.43% to -$289000.0 in 2024, then tumbled by 416.96% to -$1.5 million in 2025.
- Business Quant data shows PAVM's Income from Non-Controlling Interests at -$1.5 million in Q4 2025, -$628000.0 in Q3 2025, and -$403000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 900,000.00 |
| 10 | PAVmed | 32.79 Mn | 29.00 Mn | -89,000.00 | -1.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.21 Mn |
| Dec 31, 2025 | -1.49 Mn |
| Sep 30, 2025 | -628,000.00 |
| Jun 30, 2025 | -403,000.00 |
| Mar 31, 2025 | -345,000.00 |
| Dec 31, 2024 | -289,000.00 |
| Jun 30, 2024 | -4.09 Mn |
| Mar 31, 2024 | -3.30 Mn |
| Dec 31, 2023 | -3.37 Mn |
| Sep 30, 2023 | -4.08 Mn |
| Jun 30, 2023 | -3.36 Mn |
| Mar 31, 2023 | -4.28 Mn |
| Dec 31, 2022 | -4.11 Mn |
| Sep 30, 2022 | -3.81 Mn |
| Jun 30, 2022 | -3.58 Mn |
| Mar 31, 2022 | -2.76 Mn |
| Dec 31, 2021 | -2.46 Mn |
| Sep 30, 2021 | -1.44 Mn |
| Jun 30, 2021 | -1.20 Mn |
| Mar 31, 2021 | -679,000.00 |